GENinCode Plc (LON:GENI – Get Free Report)’s stock price fell 1.4% on Thursday . The stock traded as low as GBX 1.80 and last traded at GBX 1.87. 554,273 shares changed hands during trading, a decline of 15% from the average session volume of 654,641 shares. The stock had previously closed at GBX 1.90.
GENinCode Trading Down 13.0%
The firm has a fifty day moving average of GBX 2.34 and a 200-day moving average of GBX 2.43. The stock has a market capitalization of £2.87 million, a price-to-earnings ratio of -0.43 and a beta of 0.66. The company has a debt-to-equity ratio of 9.28, a quick ratio of 15.89 and a current ratio of 2.60.
GENinCode Company Profile
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Featured Stories
- Five stocks we like better than GENinCode
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Buy This Stock at 9:30 AM on MONDAY!
- A U.S. “birthright” claim worth trillions – activated quietly
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
